NeoGenomics, Inc. (NEO) Earnings History
Net Loss26 years of earnings data (2000–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
NeoGenomics, Inc. (NEO) Earnings Overview
As of June 13, 2026, NeoGenomics, Inc. (NEO) reported trailing twelve-month net income of -$99M, reflecting -35.5% year-over-year growth. The company earned $-3.84 per diluted share over the past four quarters, with a net profit margin of -14.9%.
Looking at the long-term picture, NEO's historical earnings data spans multiple years. The company achieved its highest annual net income of $8M in fiscal 2019.
NeoGenomics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SLNO ($96M net income, 11.0% margin), CDNA (-$8M net income, -5.6% margin), NTRA (-$226M net income, -9.0% margin), NEO has room to improve margins relative to the peer group. Compare NEO vs SLNO →
NEO Earnings vs Peers
Earnings metrics vs comparable public companies
NEO Historical Earnings Data (2000–2025)
26 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$108M | -37.2% | -$66M | $-4.20 | -14.9% | -9.1% |
| 2024 | -$79M | +10.5% | -$92M | $-3.10 | -11.9% | -13.9% |
| 2023 | -$88M | +39.0% | -$108M | $-3.50 | -14.9% | -18.2% |
| 2022 | -$144M | -1628.2% | -$158M | $-5.80 | -28.3% | -30.9% |
| 2021 | -$8M | -300.1% | -$119M | $-0.35 | -1.7% | -24.5% |
| 2020 | $4M | -47.9% | -$14M | $0.19 | 0.9% | -3.1% |
| 2019 | $8M | +203.3% | $13M | $0.39 | 2.0% | 3.2% |
| 2018 | $3M | +766.7% | $10M | $0.14 | 1.0% | 3.6% |
| 2017 | $-396,000 | +93.6% | $3M | $-0.03 | -0.2% | 1.2% |
| 2016 | -$6M | -142.3% | $3M | $-0.40 | -2.5% | 1.1% |
| 2015 | -$3M | -323.9% | -$6M | $-0.21 | -2.5% | -5.6% |
| 2014 | $1M | -44.3% | $2M | $0.10 | 1.3% | 2.5% |
| 2013 | $2M | +3027.7% | $3M | $0.20 | 3.1% | 4.8% |
| 2012 | $65,000 | +105.5% | $1M | $0.01 | 0.1% | 2.0% |
| 2011 | -$1M | +64.4% | $-409,000 | $-0.14 | -2.7% | -0.9% |
| 2010 | -$3M | -47.3% | -$3M | $-0.44 | -9.6% | -8.6% |
| 2009 | -$2M | -62.2% | -$2M | $-0.32 | -7.6% | -5.9% |
| 2008 | -$1M | +59.1% | $-884,000 | $-0.22 | -6.9% | -4.4% |
| 2007 | -$3M | -2500.0% | -$3M | $-0.55 | -29.4% | -27.3% |
| 2006 | $-130,000 | +87.0% | $139,994 | $-0.03 | -2.0% | 2.2% |
| 2005 | $-997,000 | -21.7% | $-800,000 | $-0.22 | -52.9% | -42.4% |
| 2004 | $-819,000 | -52.8% | $-730,000 | $-0.20 | -146.8% | -130.8% |
| 2003 | $-536,000 | +9.3% | $-494,000 | $-0.19 | -144.9% | -133.5% |
| 2002 | $-591,000 | +92.7% | $-584,000 | $-0.70 | -632.1% | -624.7% |
| 2001 | -$8M | -732.8% | -$8M | $-10.70 | -807800.0% | -807800.0% |
| 2000 | $-970,000 | - | $-971,000 | $-6.20 | -384.3% | -384.7% |
Download Data
Export NEO earnings history in CSV or JSON format
Free sign-in required to download data
What if you invested $1,000 in NEO back in 2000?
Total return with dividends reinvested · 26+ years of data
Calculate ReturnsHow much would $100/month in NEO be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs NEO Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationNEO vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowNEO — Frequently Asked Questions
Quick answers to the most common questions about buying NEO stock.
What is NEO earnings per share (EPS)?
NEO trailing twelve-month (TTM) diluted EPS is $-3.84, reflecting -35.5% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2000 to 2025 is available in the table on this page.
What is NeoGenomics, Inc.'s net income?
NeoGenomics, Inc. (NEO) trailing twelve-month net income is $-99M as of 2025. Earnings declined -35.5% year-over-year.
Is NEO profitable?
NEO is not currently profitable on a TTM basis, reporting a net loss of $-99M. Net margin is -14.9%. Investors should monitor for a return to profitability.
What is NEO's earnings growth rate?
NEO compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2000 to 2025.
What are NEO's profit margins?
NeoGenomics, Inc. net profit margin is -14.9%, operating margin is -9.1%, and gross margin is +38.8%. Below-average margins reflect competitive or cost pressures. Return on Equity is -12.4%.
Is NEO growing earnings?
NEO earnings are declining — EPS fell -35.5% year-over-year. TTM net income dropped to $-99M. This contrasts with the 5-year CAGR of N/A.
What was NEO's best earnings year?
NeoGenomics, Inc.'s highest annual net income on record is $8M, achieved in fiscal year 2019. Earnings history on this page spans 2000 to 2025 and includes all annual and quarterly figures.
What were NEO's earnings last quarter?
NEO's most recent reported quarter was Q1 2026. Net income was $-17M with diluted EPS of $-0.65. For a full breakdown of all quarters, see the quarterly earnings table on this page.